PT  - JOURNAL ARTICLE
AU  - Yuan-Po Tu
AU  - Jameel Iqbal
AU  - Timothy O’Leary
TI  - Evaluation of ID NOW and RT-PCR for Detection of SARS-CoV-2 in an Ambulatory Population
AID  - 10.1101/2020.12.07.20245225
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.12.07.20245225
4099  - http://medrxiv.org/content/early/2020/12/16/2020.12.07.20245225.short
4100  - http://medrxiv.org/content/early/2020/12/16/2020.12.07.20245225.full
AB  - Diagnosis of the SARS-CoV-2 (COVID-19) requires confirmation by Reverse-Transcription Polymerase Chain Reaction (RT-PCR). Abbott ID NOW provides fast results but has been criticized for low sensitivity. Here we determine the sensitivity of ID NOW in an ambulatory population presenting for testing. The study enrolled 785 symptomatic patients, 21 of whom were positive by both ID NOW and RT-PCR, and 2 only by RT-PCR. All 189 asymptomatic patients tested negative. The positive percent agreement between the ID NOW assay and the RT-PCR assay was 91.3%, and negative percent agreement was 100%. The results from the current study were included into a larger systematic review of literature where at least 20 subjects were simultaneously tested using ID NOW and RT-PCR. The overall sensitivity for ID NOW assay was calculated at 84% (95% CI 55-96%), and had the highest correlation to RT-PCR at viral loads most likely to be associated with transmissible infections.Competing Interest StatementThe Everett Clinic has received funding from Abbott which enabled Dr. Tu to complete the clinical evaluation.Funding StatementThe clinical evaluation of the ID NOW device was supported by Abbott Diagnostics.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:United Health Group Office of Human Research Affairs 160 Second Street, Third Floor Cambridge, MA 02142 FWA00028881 OHRP Registration: IORG0010356All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData included in manuscript.